Principles of Ocular Drug adminstration Flashcards

1
Q

Ocular drugs are used for?

A
  • examination
  • dx
  • tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Medical Hx considerations

A
  • Drug interactions (MOA or tricylcic antidepressants)
  • Allergy/ drug sensitivity
  • Family Hx (POAG)
  • Renal/Hepatic disease (drug metabolism)
  • Respiratory conditions (Beta blockers)
  • DM (steroid exacerbate DM)
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Considerations: Fam Hx POAG

A

Topical steroid may increase IOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Considerations: Cardiovascular disease

A
  • Hypertension - Adrenergic agonists (phenylephedrine - increase/upregulates)
  • Congestive Heart disease/Bradycardia (AV block - beta blockers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Considerations: MOA or Tricyclic anti-depressants

A

Combined with phenylephedrine may lead to cardiovascular effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Considerations: Respiratory disorders

A
  • Beta blockers - broncho-constriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Considerations: DM

A
  • systemic steroids worsen DM

- poor pupil dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Considerations: Pregnancy

A
  • Risk to fetus vs benefit to px
  • careful Cat C - latanoprost
  • risk to fetus Cat D - tetracycline
  • Cat X - def fetal risk - avoid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

phases of drug administration

A
  • absorption
  • distribution
  • metabolism
  • elimination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Compartment

A
  • region of tissue or fluid through which a drug can diffuse and equilibrate
  • each compartment is separated by a barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Barrier

A
  • region of lower permeability or restricted diffusion between compartments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Routes of drug kinetics to the eye

A
  • Trans-corneal
  • Non-corneal (scleral/Conjunctival)
  • Intravitreal (inj)
  • Cross blood retinal barrier
  • Distribution from bloodstream via blood-aqueous barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Routes of drug elimination

A
  • via TM, Schlemm’s canal , episcleral vessels(direct outflow)
  • from aqueous to bloodstream (uveal vessels - bulk transport) via blood-aqueous barrier
  • via blood-retinal barrier (retinal vessels - active transport)
  • eliminates from vitreous (sedimentary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Corneal properties

A
  • major functional barrier also major site of absorption
  • Epithelium = Lipophilic
  • Stroma = Hydrophilic
  • for full penetration requires biphasic solubility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug Kinetics - Fick’s law

A
  • Rate of drug diffusion is proportional to concentration gradient between the compartments on either side of the barrier
  • absorption affected by other drugs, preservatives, infection, inflammation & neuronal control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Kinetics - 1st order kinetics

A

most common drug movement, rate of movement is directly proportional to concentration difference across the barrier (dose = high - linear decrease then re-dose req)

17
Q

Zero - order Kinetics

A

Drug release is constant over time - slow-release (lacrisert)

18
Q

Prodrugs

A
  • Inactive derivative of drug converted to active form after tissue penetration
  • drug metabolite is more active at receptor site
  • better penetration, less side-effects
  • Latanoprost, travoprost, tafluprost
  • Valacyclovir (prodrug of acyclovir)
19
Q

Soft drugs

A
  • Compound (analog) that is rapidly transformed by enzymes to inactive form
  • fewer side effects
  • Loteprednol etabonate (analog of prednisone)
20
Q

Site specific drugs

A
  • intrinsic tissue esterases transform site specific agents into inactive metabolite shortly after entering target tissue
  • sometimes interchanged with soft drugs
21
Q

what do we need to know…

A
  • medical conditions (kidney, liver, cardiac, respirotary)
  • Other meds (drug interactions)
  • Allergies (sulfa)
  • Fam History (POAG)
  • Ocular Hx (inflammation)